EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis

被引:17
|
作者
Palacios, Santiago [1 ]
Brincat, Mark
Erel, C. Tamer [2 ]
Gambacciani, Marco [3 ]
Lambrinoudaki, Irene [4 ]
Moen, Mette H. [5 ,6 ]
Schenck-Gustafsson, Karin [7 ,8 ,9 ]
Tremollieres, Florence [10 ]
Vujovic, Svetlana [11 ]
Rees, Margaret [12 ]
Rozenberg, Serge [13 ]
机构
[1] Palacios Inst Womans Hlth Antonio Acuna, Madrid 28009, Spain
[2] Istanbul Univ, Dept Obstet & Gynecol, Cerrahpasa Med Sch, TR-34365 Istanbul, Turkey
[3] Univ Pisa, Dept Obstet & Gynecol, I-56100 Pisa, Italy
[4] Univ Athens, Dept Obstet & Gynecol 2, Aretaieio Hosp, GR-11528 Athens, Greece
[5] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, NO-7491 Trondheim, Norway
[6] Univ Trondheim Hosp, St Olavs Hosp, Dept Obstet & Gynecol, NO-7006 Trondheim, Norway
[7] Karolinska Inst, Dept Med, Cardiol Unit, SE-17176 Stockholm, Sweden
[8] Karolinska Inst, Head Ctr Gender Med, SE-17176 Stockholm, Sweden
[9] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden
[10] Hop Paule de Viguier, Menopause & Metab Bone Dis Unit, F-31059 Toulouse 09, France
[11] Belgrade Sch Med, Clin Ctr Serbia, Inst Endocrinol, Beograd 11000, Serbia
[12] John Radcliffe Hosp, Womens Ctr, Oxford OX3 9DU, England
[13] Univ Libre Bruxelles, CHU St Pierre, Dept Obstet & Gynecol, B-1000 Brussels, Belgium
关键词
Postmenopausal osteoporosis; Selective estrogen receptor modulators; Bazedoxifene; Lasofoxifene; Raloxifene; Tamoxifen; SURGICAL ADJUVANT BREAST; BAZEDOXIFENE/CONJUGATED ESTROGENS; BOWEL PROJECT; CONTROLLED PHASE-3; DOUBLE-BLIND; CANCER; WOMEN; RALOXIFENE; TAMOXIFEN; PLACEBO;
D O I
10.1016/j.maturitas.2011.11.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [1] Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis
    Meczekalski, Blazej
    Czyzyk, Adam
    GINEKOLOGIA POLSKA, 2009, 80 (03) : 213 - 217
  • [2] Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators
    Jyotsna Rani
    Swati Swati
    Meeta Meeta
    Sardar Harinder Singh
    Tanvir Tanvir
    Akanshi Madan
    Indian Journal of Orthopaedics, 2023, 57 : 105 - 114
  • [3] ASSESSING THE IMPACT OF BISPHOSPHONATES AND SELECTIVE ESTROGEN RECEPTOR MODULATORS IN POSTMENOPAUSAL OSTEOPOROSIS
    Nayyar, A.
    Raj, U.
    Rastogi, M.
    Gupta, A.
    Roy, A.
    Chopra, A.
    Pandey, S.
    Kukreja, I
    Gaur, A.
    Verma, V.
    Daral, S.
    Sethi, A.
    Dawar, V
    VALUE IN HEALTH, 2022, 25 (12) : S475 - S475
  • [4] Selective estrogen receptor modulators for postmenopausal osteoporosis - Current state of development
    Gennari, Luigi
    Merlotti, Daniela
    Valleggi, Fabrizio
    Martini, Giuseppe
    Nuti, Ranuccio
    DRUGS & AGING, 2007, 24 (05) : 361 - 379
  • [5] Postmenopausal Osteoporosis: Menopause Hormone Therapy and Selective Estrogen Receptor Modulators
    Rani, Jyotsna
    Swati, Swati
    Meeta, Meeta
    Singh, Sardar Harinder
    Tanvir, Tanvir
    Madan, Akanshi
    INDIAN JOURNAL OF ORTHOPAEDICS, 2023, 57 (SUPPL 1) : 105 - 114
  • [6] Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide
    Cano, Antonio
    Chedraui, Peter
    Goulis, Dimitrios G.
    Lopes, Patrice
    Mishra, Gita
    Mueck, Alfred
    Senturk, Levent M.
    Simoncini, Tommaso
    Stevenson, John C.
    Stute, Petra
    Tuomikoski, Pauliina
    Rees, Margaret
    Lambrinoudaki, Irene
    MATURITAS, 2018, 107 : 7 - 12
  • [7] Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?
    Gold D.T.
    Silverman S.L.
    Current Osteoporosis Reports, 2007, 5 (1) : 3 - 7
  • [8] Hormone substitution and selective estrogen receptor modulators (SERMs) for prophylaxis and therapy of postmenopausal osteoporosis
    Pfeilschifter, J
    ORTHOPADE, 2001, 30 (07): : 462 - 472
  • [9] Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis
    Fontana, A
    Delmas, PD
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2003, 32 (01) : 219 - +
  • [10] The evolution of selective estrogen receptor modulators in osteoporosis therapy
    Hadji, P.
    CLIMACTERIC, 2012, 15 (06) : 513 - 523